Richard Press

Professor

  • 2278 Citations
  • 26 h-Index
1982 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 5 Similar Profiles
Mutation Medicine & Life Sciences
Hemochromatosis Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Genetic Testing Medicine & Life Sciences
Iron Overload Medicine & Life Sciences
Polymerase Chain Reaction Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1991 2006

Bcr-Abl RNA levels to monitor STI571 leukemia therapy

Press, R.

National Institutes of Health

2/14/031/31/06

Project: Research projectExploratory/Developmental Grants

Leukemia
RNA
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Therapeutics
Imatinib Mesylate
Oncogene Proteins
Transcription Factor TFIIB
Trans-Activators
Gene Expression
myb Genes

STRUCTURE AND FUNCTION OF MYB ONCOGENE IN NEURONAL CELLS

Press, R.

National Institutes of Health

7/1/916/30/94

Project: Research projectClinical Investigator Award (CIA)

myb Genes
Neuroblastoma
Proto-Oncogene Proteins c-myb
Brain
Internship and Residency

Research Output 1982 2018

  • 2278 Citations
  • 26 h-Index
  • 92 Article
  • 5 Chapter
  • 1 Letter
  • 1 Review article

Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS

Alberti, M. O., Srivatsan, S. N., Shao, J., McNulty, S. N., Chang, G. S., Miller, C. A., Dunlap, J. B., Yang, F., Press, R. D., Gao, Q., Ding, L., Heusel, J. W., Duncavage, E. J. & Walter, M. J. Jun 29 2018 (Accepted/In press) In : Leukemia. p. 1-5 5 p.

Research output: Contribution to journalArticle

Artifacts
Mutation
Neoplasms
1 Citations
Large Granular Lymphocytic Leukemia
Hematopoiesis
Mutation
3 Citations

CRISPR-Cas9–mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy

Ma, L., Boucher, J. I., Paulsen, J., Matuszewski, S., Eide, C. A., Ou, J., Eickelberg, G., Press, R. D., Zhu, L. J., Druker, B. J., Branford, S., Wolfe, S. A., Jensen, J. D., Schiffer, C. A., Green, M. R. & Bolon, D. N. Oct 31 2017 In : Proceedings of the National Academy of Sciences of the United States of America. 114, 44, p. 11751-11756 6 p.

Research output: Contribution to journalArticle

Clustered Regularly Interspaced Short Palindromic Repeats
Drug Resistance
Mutagenesis
Mutation
Oncogenes

DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML

Ma, J., Dunlap, J., Paliga, A., Traer, E., Press, R., Shen, L. & Fan, G. Nov 23 2017 (Accepted/In press) In : Leukemia and Lymphoma. p. 1-11 11 p.

Research output: Contribution to journalArticle

Cytogenetics
Mutation
Genes
Cohort Studies
Recurrence
1 Citations

Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices

Arora, R. & Press, R. D. Jan 2 2017 In : Leukemia and Lymphoma. 58, 1, p. 8-16 9 p.

Research output: Contribution to journalReview article

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Practice Guidelines
RNA
Protein-Tyrosine Kinases
Real-Time Polymerase Chain Reaction